We are live on
!
Find out more
Focus Partners Wealth Portfolio holdings
AUM
$89.9B
1-Year Est. Return
20.5%
This Fund
S&P 500
This Quarter
Est. Return
-1.63%
1 Year Est. Return
+20.5%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$39.9B
AUM Growth
+$1.4B
(+3.6%)
Cap. Flow
+$2.47B
Cap. Flow
% of AUM
6.2%
Top 10 Holdings %
Top 10 Hldgs %
20.34%
Holding
2,063
New
173
Increased
919
Reduced
734
Closed
170
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Avantis US Small Cap Value ETF
AVUV
|
+$368M |
| 2 |
Dimensional US High Profitability ETF
DUHP
|
+$288M |
| 3 |
Dimensional International Small Cap Value ETF
DISV
|
+$263M |
| 4 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$231M |
| 5 |
iShares S&P 100 ETF
OEF
|
+$213M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Stock Market ETF
VTI
|
+$81.3M |
| 2 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$39.9M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$39.7M |
| 4 |
BondBloxx Bloomberg One Year Target Duration US Treasury ETF
XONE
|
+$37.5M |
| 5 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$31.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Financials | 7.28% |
| 3 | Consumer Discretionary | 4.54% |
| 4 | Healthcare | 4.28% |
| 5 | Consumer Staples | 3.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Standard BioTools
LAB
$311M
| $16.5K | ﹤0.01% |
15,282
+1,227
| +9% | +$1.72K |
|
1877
Galectin Therapeutics
GALT
$223M
| $16.3K | ﹤0.01% |
13,330
-1,921
| -13% | -$2.69K |
|
1878
Tilray
TLRY
$498M
| $15.9K | ﹤0.01% |
2,417
-260
| -10% | -$2.41K |
|
1879
GEE Group
JOB
$23.1M
| $15.2K | ﹤0.01% |
75,084
| – | – |
|
1880
DarioHealth
DRIO
$54.8M
| $14.7K | ﹤0.01% |
1,202
| – | – |
|
1881
GoPro
GPRO
$125M
| $10.9K | ﹤0.01% |
+16,446
| New | +$14.5K |
|
1882
RenovoRx
RNXT
$40.9M
| $10.9K | ﹤0.01% |
+11,000
| New | +$12.8K |
|
|
MRSN
1883
DELISTED
Mersana Therapeutics
MRSN
| $10.5K | ﹤0.01% |
+1,221
| New | +$18.8K |
|
1884
Veru
VERU
$35.8M
| $10.5K | ﹤0.01% |
2,133
+13
| +0.6% | +$81 |
|
|
SGMO
1885
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $9.38K | ﹤0.01% |
14,300
-900
| -6% | -$953 |
|
1886
Nektar Therapeutics
NKTR
$2.39B
| $8.79K | ﹤0.01% |
+861
| New | +$11.3K |
|
1887
Coherus Oncology
CHRS
$222M
| $8.76K | ﹤0.01% |
+10,857
| New | +$12.5K |
|
1888
Tenaya Therapeutics
TNYA
$164M
| $6.99K | ﹤0.01% |
+12,263
| New | +$12.1K |
|
|
URG
1889
Ur-Energy
URG
$481M
| $6.96K | ﹤0.01% |
10,324
+324
| +3% | +$318 |
|
1890
X4 Pharmaceuticals
XFOR
$371M
| $6.14K | ﹤0.01% |
866
+32
| +4% | +$441 |
|
1891
Stem
STEM
$47.7M
| $5.22K | ﹤0.01% |
+746
| New | +$8.64K |
|
|
NOVA
1892
DELISTED
Sunnova Energy
NOVA
| $5K | ﹤0.01% |
+13,445
| New | +$25.9K |
|
|
AMRN
1893
Amarin Corp
AMRN
$293M
| $4.48K | ﹤0.01% |
+500
| New | +$5.29K |
|
|
VXRT
1894
DELISTED
Vaxart
VXRT
| $4.48K | ﹤0.01% |
11,000
-6,650
| -38% | -$4.26K |
|
|
ARBK
1895
Argo Blockchain
ARBK
$42.1M
| $4.01K | ﹤0.01% |
55
| – | – |
|
|
BURU
1896
DELISTED
NUBURU INC
BURU
| $2.68K | ﹤0.01% |
+2,841
| New | +$4.46K |
|
1897
CALL
Apple
AAPL
$4.99T
| – | – |
-100
| Closed | -$3.44K |
|
1898
PUT
AbbVie
ABBV
$465B
| – | – |
-5,500
| Closed | -$977K |
|
1899
Arcosa
ACA
$7.13B
| – | – |
-2,974
| Closed | -$288K |
|
1900
CALL
Archer Aviation
ACHR
$3.68B
| – | – |
-200
| Closed | -$790 |
|
Similar funds
Focus Partners Wealth's Q1 2025 Portfolio in Review
As of Q1 2025, Focus Partners Wealth held 2,063 positions worth $39.9B, up 3.6% from $38.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Focus Partners Wealth deployed $2.47B of net new capital in Q1 2025, opening 173 new positions and adding to 919 existing holdings. Its largest new stake was Avantis Responsible US Equity ETF: 326,840 shares worth $20.4M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard Total Stock Market ETF, an estimated $81.3M trimmed.
- Focus Partners Wealth's largest Q1 2025 buy was Avantis Responsible US Equity ETF: 326,840 shares worth $20.4M.
- Focus Partners Wealth added most to Avantis US Small Cap Value ETF in Q1 2025, an estimated $368M increase.
- Focus Partners Wealth's biggest Q1 2025 reduction was Vanguard Total Stock Market ETF, cutting an estimated $81.3M.
- Focus Partners Wealth fully exited BondBloxx Bloomberg One Year Target Duration US Treasury ETF in Q1 2025, selling an estimated $37.5M.
- Focus Partners Wealth's ten largest holdings make up 20% of its $39.9B portfolio in Q1 2025.
- Focus Partners Wealth opened 173 new positions and closed 170 in Q1 2025.
- Focus Partners Wealth's portfolio value rose 3.6% quarter-over-quarter to $39.9B.
Based on Focus Partners Wealth's 13F filing for Q1 2025, filed 15 May 2025.